Navigating the microbial community in the trachea-oropharynx of breast cancer patients with or without neoadjuvant chemotherapy (NAC) via endotracheal tube: has NAC caused any change?

• Published in: PeerJ (San Francisco, CA) Vol. 11; p. e16366
• Main Authors: Kim, Hee Yeon, Kim, Tae Hyun, Shin, Jeong Hwan, Cho, Kwangrae, Ha, Heon-Kyun, Lee, Anbok, Kim, Young Jin
• Format: Journal Article
• Language: English
• Published: San Diego PeerJ. Ltd 23.11.2023; PeerJ, Inc; PeerJ Inc
• Subjects: Adjuvant treatment; Analysis; Biological diversity; Breast cancer; Cancer; Cancer patients; Care and treatment; Chemotherapy; Cytotoxicity; Diabetes; Discriminant analysis; Diversity indices; Hemoglobin; Lower respiratory tract; Microbiome; Microbiomes; Microbiota; Neoadjuvant chemotherapy; Oropharynx; Pertuzumab; Respiratory tract; RNA; rRNA 16S; Surgery; Trachea; United States > US
• ISSN: 2167-8359; 2167-8359
• DOI: 10.7717/peerj.16366

Background We compare the diversity and niche specificity of the microbiome in the trachea-oropharynx microbiome of malignant breast neoplasm with or without neoadjuvant chemotherapy (NAC) via NGS analysis. Methods We prospectively collected a total of 40 endotracheal tubes intubated from subjects, of whom 20 with NAC treated breast cancer (NAC group) and 20 with breast cancer without NAC (Non-NAC group). We generated 16S rRNA-based microbial profiles in IlluminaTM platform and alpha diversity indices were compared between groups. For the comparison of taxa abundance, linear discriminant analysis effect size method with Kruskal-Wallis test was used. The distribution of variables between the two groups was compared using the Mann-Whitney test. For beta diversity analysis, PERMANOVA was used. Results Among the diversity indices, the NAC group showed significantly lower Chao1, Inverse Simpson, and Shannon indices than the Non-NAC group. The three most frequent taxa of all two groups were Streptococcus (20.4%), followed by Veillonella (11.9%), and Prevorella (10.4%). This order was the same in NAC and non-NAC groups. Conclusion Here, we provide the first comparison data of the respiratory tract microbiome of breast cancer patients with or without NAC via NGS analysis. This study ultimately seeks to contribute to future studies on the lower respiratory tract in cancer patients with cytotoxic chemotherapy by establishing reliable control data.